Ani Pharmaceuticals reported $-8600000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US USD 3.95B 3.03B
Aerie Pharmaceuticals AERI:US USD -26826000 7.46M
Ani Pharmaceuticals ANIP:US USD -8600000 6.32M
Aurora Cannabis Inc ACB:CN CAD -51604000 567.18M
Canopy Growth Corp WEED:CN CAD -221806000 1.86B
Eli Lilly And LLY:US USD 1.45B 499.2M
Endo International Ordinary Shares ENDP:US USD -722169000 1.16B
Hikma Pharmaceutical HIK:LN USD 173M 0
Knight Therapeutics Inc GUD:CN CAD 1.59M 925K
Lannett LCI:US USD -28019000 65.28M
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Novartis NVS:US USD 1.57B 121M
Omeros OMER:US USD -17456000 13.39M
Perrigo Ordinary Shares PRGO:US USD -49400000 15.7M
Sun Pharmaceuticals SUNP:IN INR 22.62B 2.01B
Teva Pharmaceutical TEVA:IT USD 55M 288M
Teva Pharmaceutical Industries TEVA:US USD 55M 288M